- call +1-201-465-4211
- email sales@mrinsights.biz
Antimicrobial peptides (AMPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
Scope of the Report:
This report focuses on the Anti Microbial Peptides in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Global anti-microbial peptides market is segmented on the basis of peptides types such as plant anti-microbial peptides, bacterial anti-microbial peptides, animal anti-microbial peptides, insect anti-microbial peptides. Among these segments, animal and plant anti-microbial peptides are capturing the major share into the market as they are easy to extract as compared with other anti-microbial peptides. Researchers are also more inclined towards animal and plant anti-microbial peptides to observe and check under clinical trials.
Europe and North America are the leading regions in global anti-microbial peptide market owing to the large investment in R&D and healthcare industry. Europe anti-microbial peptides market valued USD 0.39 billion in 2016, and is projected to grow at a CAGR of 9.0% during the forecast period. There are approximately 45 peptides which are approved globally and are being used in different verticals out of which 5-6 are from Europe. European Union has announced to invest USD 1.7 billion to develop antimicrobial peptide drugs to tackle against drug-resistant bacteria. Europe was marketed for nearly 110 peptides in clinical trials and more than 150 peptides in advanced pre-clinical phase. Germany and the UK hold the major share of antimicrobial peptides market. Moreover, Greece is the largest and only producer of generic peptides of European Union.
The worldwide market for Anti Microbial Peptides is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
AnaSpec
Novozymes
Bachem
Phoenix Biotech
AMP Biotech
Shanghai Abbiochem Company
Ramamoorthy Group
Lytix Biopharma
Ai2
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Plant Anti-Microbial Peptides
Bacterial Anti-Microbial Peptides
Animal Anti-Microbial Peptides
Insects Anti-Microbial Peptides
Market Segment by Applications, can be divided into
Personal Care and Cosmetics Industry
Healthcare & Pharmaceuticals Industry
Biotechnology Industry
There are 15 Chapters to deeply display the global Anti Microbial Peptides market.
Chapter 1, to describe Anti Microbial Peptides Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Anti Microbial Peptides, with sales, revenue, and price of Anti Microbial Peptides, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti Microbial Peptides, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Anti Microbial Peptides market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Anti Microbial Peptides sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Anti Microbial Peptides Introduction
1.2 Market Analysis by Type
1.2.1 Plant Anti-Microbial Peptides
1.2.2 Bacterial Anti-Microbial Peptides
1.2.3 Animal Anti-Microbial Peptides
1.2.4 Insects Anti-Microbial Peptides
1.3 Market Analysis by Applications
1.3.1 Personal Care and Cosmetics Industry
1.3.2 Healthcare & Pharmaceuticals Industry
1.3.3 Biotechnology Industry
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AnaSpec
2.1.1 Business Overview
2.1.2 Anti Microbial Peptides Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AnaSpec Anti Microbial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novozymes
2.2.1 Business Overview
2.2.2 Anti Microbial Peptides Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novozymes Anti Microbial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bachem
2.3.1 Business Overview
2.3.2 Anti Microbial Peptides Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bachem Anti Microbial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Phoenix Biotech
2.4.1 Business Overview
2.4.2 Anti Microbial Peptides Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Phoenix Biotech Anti Microbial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 AMP Biotech
2.5.1 Business Overview
2.5.2 Anti Microbial Peptides Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AMP Biotech Anti Microbial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Shanghai Abbiochem Company
2.6.1 Business Overview
2.6.2 Anti Microbial Peptides Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Shanghai Abbiochem Company Anti Microbial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Ramamoorthy Group
2.7.1 Business Overview
2.7.2 Anti Microbial Peptides Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Ramamoorthy Group Anti Microbial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Lytix Biopharma
2.8.1 Business Overview
2.8.2 Anti Microbial Peptides Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Lytix Biopharma Anti Microbial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Ai2
2.9.1 Business Overview
2.9.2 Anti Microbial Peptides Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Ai2 Anti Microbial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anti Microbial Peptides Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Anti Microbial Peptides Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anti Microbial Peptides Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti Microbial Peptides Manufacturer Market Share in 2017
3.3.2 Top 6 Anti Microbial Peptides Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Anti Microbial Peptides Market Analysis by Regions
4.1 Global Anti Microbial Peptides Sales, Revenue and Market Share by Regions
4.1.1 Global Anti Microbial Peptides Sales and Market Share by Regions (2013-2018)
4.1.2 Global Anti Microbial Peptides Revenue and Market Share by Regions (2013-2018)
4.2 North America Anti Microbial Peptides Sales and Growth Rate (2013-2018)
4.3 Europe Anti Microbial Peptides Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Anti Microbial Peptides Sales and Growth Rate (2013-2018)
4.5 South America Anti Microbial Peptides Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Anti Microbial Peptides Sales and Growth Rate (2013-2018)
5 North America Anti Microbial Peptides by Countries
5.1 North America Anti Microbial Peptides Sales, Revenue and Market Share by Countries
5.1.1 North America Anti Microbial Peptides Sales and Market Share by Countries (2013-2018)
5.1.2 North America Anti Microbial Peptides Revenue and Market Share by Countries (2013-2018)
5.2 United States Anti Microbial Peptides Sales and Growth Rate (2013-2018)
5.3 Canada Anti Microbial Peptides Sales and Growth Rate (2013-2018)
5.4 Mexico Anti Microbial Peptides Sales and Growth Rate (2013-2018)
6 Europe Anti Microbial Peptides by Countries
6.1 Europe Anti Microbial Peptides Sales, Revenue and Market Share by Countries
6.1.1 Europe Anti Microbial Peptides Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Anti Microbial Peptides Revenue and Market Share by Countries (2013-2018)
6.2 Germany Anti Microbial Peptides Sales and Growth Rate (2013-2018)
6.3 UK Anti Microbial Peptides Sales and Growth Rate (2013-2018)
6.4 France Anti Microbial Peptides Sales and Growth Rate (2013-2018)
6.5 Russia Anti Microbial Peptides Sales and Growth Rate (2013-2018)
6.6 Italy Anti Microbial Peptides Sales and Growth Rate (2013-2018)
7 Asia-Pacific Anti Microbial Peptides by Countries
7.1 Asia-Pacific Anti Microbial Peptides Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anti Microbial Peptides Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Anti Microbial Peptides Revenue and Market Share by Countries (2013-2018)
7.2 China Anti Microbial Peptides Sales and Growth Rate (2013-2018)
7.3 Japan Anti Microbial Peptides Sales and Growth Rate (2013-2018)
7.4 Korea Anti Microbial Peptides Sales and Growth Rate (2013-2018)
7.5 India Anti Microbial Peptides Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Anti Microbial Peptides Sales and Growth Rate (2013-2018)
8 South America Anti Microbial Peptides by Countries
8.1 South America Anti Microbial Peptides Sales, Revenue and Market Share by Countries
8.1.1 South America Anti Microbial Peptides Sales and Market Share by Countries (2013-2018)
8.1.2 South America Anti Microbial Peptides Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Anti Microbial Peptides Sales and Growth Rate (2013-2018)
8.3 Argentina Anti Microbial Peptides Sales and Growth Rate (2013-2018)
8.4 Colombia Anti Microbial Peptides Sales and Growth Rate (2013-2018)
9 Middle East and Africa Anti Microbial Peptides by Countries
9.1 Middle East and Africa Anti Microbial Peptides Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anti Microbial Peptides Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Anti Microbial Peptides Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Anti Microbial Peptides Sales and Growth Rate (2013-2018)
9.3 UAE Anti Microbial Peptides Sales and Growth Rate (2013-2018)
9.4 Egypt Anti Microbial Peptides Sales and Growth Rate (2013-2018)
9.5 Nigeria Anti Microbial Peptides Sales and Growth Rate (2013-2018)
9.6 South Africa Anti Microbial Peptides Sales and Growth Rate (2013-2018)
10 Global Anti Microbial Peptides Market Segment by Type
10.1 Global Anti Microbial Peptides Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anti Microbial Peptides Sales and Market Share by Type (2013-2018)
10.1.2 Global Anti Microbial Peptides Revenue and Market Share by Type (2013-2018)
10.2 Plant Anti-Microbial Peptides Sales Growth and Price
10.2.1 Global Plant Anti-Microbial Peptides Sales Growth (2013-2018)
10.2.2 Global Plant Anti-Microbial Peptides Price (2013-2018)
10.3 Bacterial Anti-Microbial Peptides Sales Growth and Price
10.3.1 Global Bacterial Anti-Microbial Peptides Sales Growth (2013-2018)
10.3.2 Global Bacterial Anti-Microbial Peptides Price (2013-2018)
10.4 Animal Anti-Microbial Peptides Sales Growth and Price
10.4.1 Global Animal Anti-Microbial Peptides Sales Growth (2013-2018)
10.4.2 Global Animal Anti-Microbial Peptides Price (2013-2018)
10.5 Insects Anti-Microbial Peptides Sales Growth and Price
10.5.1 Global Insects Anti-Microbial Peptides Sales Growth (2013-2018)
10.5.2 Global Insects Anti-Microbial Peptides Price (2013-2018)
11 Global Anti Microbial Peptides Market Segment by Application
11.1 Global Anti Microbial Peptides Sales Market Share by Application (2013-2018)
11.2 Personal Care and Cosmetics Industry Sales Growth (2013-2018)
11.3 Healthcare & Pharmaceuticals Industry Sales Growth (2013-2018)
11.4 Biotechnology Industry Sales Growth (2013-2018)
12 Anti Microbial Peptides Market Forecast (2018-2023)
12.1 Global Anti Microbial Peptides Sales, Revenue and Growth Rate (2018-2023)
12.2 Anti Microbial Peptides Market Forecast by Regions (2018-2023)
12.2.1 North America Anti Microbial Peptides Market Forecast (2018-2023)
12.2.2 Europe Anti Microbial Peptides Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anti Microbial Peptides Market Forecast (2018-2023)
12.2.4 South America Anti Microbial Peptides Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anti Microbial Peptides Market Forecast (2018-2023)
12.3 Anti Microbial Peptides Market Forecast by Type (2018-2023)
12.3.1 Global Anti Microbial Peptides Sales Forecast by Type (2018-2023)
12.3.2 Global Anti Microbial Peptides Market Share Forecast by Type (2018-2023)
12.4 Anti Microbial Peptides Market Forecast by Application (2018-2023)
12.4.1 Global Anti Microbial Peptides Sales Forecast by Application (2018-2023)
12.4.2 Global Anti Microbial Peptides Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Anti Microbial Peptides Picture
Table Product Specifications of Anti Microbial Peptides
Figure Global Sales Market Share of Anti Microbial Peptides by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
